LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Penumbra Inc

Închisă

SectorSănătate

320.7 0.4

Rezumat

Modificarea prețului

24h

Curent

Minim

319.37

Maxim

321.56

Indicatori cheie

By Trading Economics

Venit

163M

33M

Vânzări

-11M

375M

P/E

Medie Sector

73.491

49.888

EPS

0.82

Marjă de profit

8.695

Angajați

4,700

EBITDA

-30M

38M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+12.17% upside

Dividende

By Dow Jones

Următoarele câștiguri

28 iul. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-224M

13B

Deschiderea anterioară

320.3

Închiderea anterioară

320.7

Sentimentul știrilor

By Acuity

50%

50%

154 / 344 Clasament în Healthcare

Penumbra Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 ian. 2026, 13:29 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 ian. 2026, 12:35 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 ian. 2026, 12:29 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

6 mai 2026, 20:15 UTC

Câștiguri

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6 mai 2026, 20:07 UTC

Câștiguri

Penumbra 1Q Rev $374.8M >PEN

6 mai 2026, 20:07 UTC

Câștiguri

Penumbra 1Q EPS 82c >PEN

25 feb. 2026, 18:02 UTC

Câștiguri

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

25 feb. 2026, 18:01 UTC

Câștiguri

Penumbra 4Q Rev $385.4M >PEN

25 feb. 2026, 18:01 UTC

Câștiguri

Penumbra 4Q Adj EPS $1.18 >PEN

25 feb. 2026, 18:01 UTC

Câștiguri

Penumbra 4Q EPS $1.20 >PEN

24 ian. 2026, 06:18 UTC

Achiziții, Fuziuni, Preluări

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

15 ian. 2026, 14:37 UTC

Acțiuni populare

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 ian. 2026, 13:45 UTC

Achiziții, Fuziuni, Preluări

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 ian. 2026, 12:04 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 ian. 2026, 12:03 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 ian. 2026, 12:01 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 ian. 2026, 12:00 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 ian. 2026, 12:00 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Comparație

Modificare preț

Penumbra Inc Așteptări

Obiectiv de preț

By TipRanks

12.17% sus

Prognoză pe 12 luni

Medie 358.25 USD  12.17%

Maxim 374 USD

Minim 335 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPenumbra Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

4 ratings

1

Cumpărare

3

Păstrare

0

Vânzare

Sentiment

By Acuity

154 / 344 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat